Dexmedetomidine Sedation in Children With Respiratory Morbidities

• Status: Completed
• Trial end date: 2015-07-01
• Target enrollment: 0
• Participant gender: All

Summary

This study aimed to determine the feasibility of dexmedetomidine in children with respiratory morbidities who required deep sedation for magnetic resonance imaging (MRI) scans.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Universitair Ziekenhuis Brussel
• Treatments: Dexmedetomidine

Criteria

Inclusion Criteria:

• Children up to the age of 16 years with at least 3 characteristics of respiratory morbidities

Exclusion Criteria:

• Children who had an American Society of Anaesthesiologists (ASA) physical status classification IV

• Documented pre-existing cardiac conduction abnormalities

• Renal impairment